Wednesday, May 9, 2018
Cancer Therapy 2018
PULSUS, a renowned organization that organizes highly noteworthy conferences throughout the globe invites participants from all over the world to attend “3rd World Congress on Advanced Cancer Science & Therapy” under the theme “An Assembly of Curious Facts and Cure for Cancer” during October 15-16, 2018 in Osaka, Japan. This includes prompt Keynote presentations, Oral talks, Poster presentations, Workshops and Exhibitions.
Cancer is a disease in which cells grow abnormally and have the potential to spread to different parts. The abnormal growths without being harmful are called the benign tumors or the non-cancerous growths. Those cells which divide uncontrollably and spread to the nearby tissues are called the malignant tumors or the cancerous growths. The spread form the primary site (the place it originated) to the secondary site is called metastasis. The causative agents of cancer are called carcinogens. There are different types of cancers named based on their origin of development. These days many advancements have come in the field of cancer starting from diagnosis, treatment and prevention.
Cancer Therapy 2018 conference is aiming to fulfil the thirst of research minds with its keynote sessions of eminent professionals, oral and poster presentations from young minds and innovative scholars. We hope to provide you a valuable time and opportunity to meet and interact with professionals and researchers from all through the globe.
Breast Cancer Cancer occurs when changes called mutations take place in genes that regulate cell growth. The mutations let the cells di...
#MolecularDiagnostics involves the different tests to examine #DNA, #RNA and #Protein for #diagnosis, #prognosis and #prediction purpo...
#Operomics- Integration of #genomics, #proteomics and #transcriptomics to understand the #molecularmechanisms responsible for the develop...
Case study refers to the in depth analysis and here it deals with the analysis of cancer patients and reports from doctors who had tre...